<DOC>
	<DOCNO>NCT03037372</DOCNO>
	<brief_summary>This study determine whether 36 month daily atorvastatin rosuvastatin equivalent effect reduction immune activation , inflammation immune aging , give adjunct therapy among patient receive antiretroviral therapy African cohort</brief_summary>
	<brief_title>Statin Adjunct Therapy Among ART-treated Adults Sub-Saharan Africa : Atorvastatin Rosuvastatin Equivalence Trial</brief_title>
	<detailed_description>This randomize , open-label trial</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>HIVpositive individual 18 year old , initiate three firstline drug highly active antiretroviral therapy within three month within Infectious Diseases Institute HIV treatment cohort Individuals provide write informed consent participate clinical trial Individuals dyslipidemia eligible receive already receive statin therapy Pregnant lactating mother Individuals another active control inflammatory condition Individuals derange liver function test 3 fold</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>adult</keyword>
	<keyword>antiretroviral therapy</keyword>
</DOC>